Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SEVITENSION
2009-012966-30Phase 4Completed
- Sponsor
- Daiichi Sankyo Co., Ltd.
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of olmesartan medoxomil + amlodipine, perindopril and amlodipine in essential hypertension (2 arms), sponsored by Daiichi Sankyo Co., Ltd. Primary endpoint: Mean change in central systolic blood pressure. Started Sep 2009; status: completed.
02
Drugs
olmesartan medoxomil + amlodipineperindoprilamlodipine
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2009-012966-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012966-30.